ES2078251T3 - Sistema para la distribucion regulada de agentes activos y proceso para su preparacion. - Google Patents
Sistema para la distribucion regulada de agentes activos y proceso para su preparacion.Info
- Publication number
- ES2078251T3 ES2078251T3 ES90101888T ES90101888T ES2078251T3 ES 2078251 T3 ES2078251 T3 ES 2078251T3 ES 90101888 T ES90101888 T ES 90101888T ES 90101888 T ES90101888 T ES 90101888T ES 2078251 T3 ES2078251 T3 ES 2078251T3
- Authority
- ES
- Spain
- Prior art keywords
- release
- preparation
- pharmaceutical
- controlled
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- External Artificial Organs (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Operation Control Of Excavators (AREA)
Abstract
EL INVENTO SE REFIERE A UN SISTEMA PARA CONTROLAR LA REALIZACION DE AGENTES ACTIVOS Y PROCESO PARA SU PREPARACION, PREFERIBLEMENTE UNA PREPARACION FARMACEUTICA ADMINISTRABLE POR VIA ORAL, ESPECIALMENTE SOLUBLES, AGENTES FARMACEUTICOS TENIENDO SIEMPRE UN AGENTE ACTIVO CAUSADO POR UN PROCESO DE CONVECTIVO. EL SISTEMA DEL INVENTO ES SIMILAR EN EFECTIVIDAD EN LA TERAPEUTICA INTRAVENOSA COMO POR EJEMPLO LA REALIZACION COMPLETA DE UN AGENTE ACTIVO DE UN PREPARADO FARMACEUTICO PARA PERIODOS DE PRACTICAS TERAPEUTICAS Y PSICOLOGICAS CAUSADAS POR PROCESOS CONVECTIVOS. ESTO LLEVA A UN NIVEL CONSTANTE DE LA SANGRE QUE GARANTIZA EL EFECTO DE LARGA DURACION DE LA DROGA MIENTRAS QUE REDUCE LOS EFECTOS ADVERSOS Y MEJORA LA TOLERANCIA LOCAL DEL TRACTO GASTROINTESTINAL AL MISMO TIEMPO. CON DICHA COMPOSICION DE LA PREPARACION FARMACEUTICA Y EL PROCESO DE ESTA PREPARACION PERJUDICA LA REALIZACION DE LOS AGENTES FARMACEUTICOS QUE NO SON USUALES EN EL CASO DE LA REALIZACION DEL AGENTE FARMACEUTICO, Y LA PRESENTE REALIZACION SE PODRA HACER EN UN CORTO PERIODO DE TIEMPO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DD89325354A DD295760A5 (de) | 1989-01-31 | 1989-01-31 | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
DE19893932987 DE3932987A1 (de) | 1989-10-03 | 1989-10-03 | System fuer die kontrollierte freisetzung von wirkstoffen und verfahren zu seiner herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2078251T3 true ES2078251T3 (es) | 1995-12-16 |
Family
ID=25748261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90101888T Expired - Lifetime ES2078251T3 (es) | 1989-01-31 | 1990-01-31 | Sistema para la distribucion regulada de agentes activos y proceso para su preparacion. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0381181B1 (es) |
JP (1) | JP2885858B2 (es) |
AT (1) | ATE126052T1 (es) |
AU (1) | AU641136B2 (es) |
CA (1) | CA2009045A1 (es) |
DE (1) | DE69021405T2 (es) |
DK (1) | DK0381181T3 (es) |
ES (1) | ES2078251T3 (es) |
FI (1) | FI900470A0 (es) |
GR (1) | GR3017861T3 (es) |
HU (1) | HU205851B (es) |
IE (1) | IE69174B1 (es) |
NO (1) | NO301520B1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ238867A (en) * | 1990-07-12 | 1993-08-26 | Alza Corp | Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
WO1996019974A1 (fr) * | 1994-12-27 | 1996-07-04 | Kanebo, Ltd. | Preparation a liberation prolongee |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
US6074669A (en) * | 1997-01-20 | 2000-06-13 | Ranbaxy Laboratories Limited | Controlled drug delivery system for diltiazem |
JP4848101B2 (ja) * | 2001-08-17 | 2011-12-28 | 株式会社フジモト・コーポレーション | 徐放性マイクロペレット |
US7621907B2 (en) * | 2002-03-11 | 2009-11-24 | Alcon, Inc. | Implantable drug delivery system |
US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
GB2150434B (en) * | 1983-12-01 | 1987-11-04 | Alza Corp | Constant rate release systems |
US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
DE3769707D1 (de) * | 1986-06-17 | 1991-06-06 | Recordati Chem Pharm | Therapeutisches system mit geregelter wirkstoffabgabe. |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
-
1990
- 1990-01-30 JP JP2021910A patent/JP2885858B2/ja not_active Expired - Lifetime
- 1990-01-30 HU HU90591A patent/HU205851B/hu not_active IP Right Cessation
- 1990-01-30 IE IE33690A patent/IE69174B1/en not_active IP Right Cessation
- 1990-01-30 FI FI900470A patent/FI900470A0/fi not_active IP Right Cessation
- 1990-01-30 NO NO900428A patent/NO301520B1/no unknown
- 1990-01-31 EP EP90101888A patent/EP0381181B1/en not_active Expired - Lifetime
- 1990-01-31 DE DE69021405T patent/DE69021405T2/de not_active Expired - Fee Related
- 1990-01-31 CA CA002009045A patent/CA2009045A1/en not_active Abandoned
- 1990-01-31 DK DK90101888.7T patent/DK0381181T3/da active
- 1990-01-31 AU AU48988/90A patent/AU641136B2/en not_active Ceased
- 1990-01-31 AT AT90101888T patent/ATE126052T1/de not_active IP Right Cessation
- 1990-01-31 ES ES90101888T patent/ES2078251T3/es not_active Expired - Lifetime
-
1995
- 1995-10-25 GR GR950402965T patent/GR3017861T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH02282324A (ja) | 1990-11-19 |
HU900591D0 (en) | 1990-04-28 |
EP0381181A3 (en) | 1991-09-18 |
NO301520B1 (no) | 1997-11-10 |
GR3017861T3 (en) | 1996-01-31 |
EP0381181B1 (en) | 1995-08-09 |
JP2885858B2 (ja) | 1999-04-26 |
DK0381181T3 (da) | 1995-10-30 |
FI900470A0 (fi) | 1990-01-30 |
AU641136B2 (en) | 1993-09-16 |
EP0381181A2 (en) | 1990-08-08 |
ATE126052T1 (de) | 1995-08-15 |
HU205851B (en) | 1992-07-28 |
NO900428L (no) | 1990-08-01 |
IE69174B1 (en) | 1996-08-07 |
IE900336L (en) | 1990-07-31 |
DE69021405D1 (de) | 1995-09-14 |
DE69021405T2 (de) | 1996-04-11 |
AU4898890A (en) | 1990-08-09 |
NO900428D0 (no) | 1990-01-30 |
CA2009045A1 (en) | 1990-07-31 |
HUT53284A (en) | 1990-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
DK1227806T3 (da) | Farmaceutisk præparat indeholdende tolterodin og dets anvendelse | |
DK0610595T3 (da) | Sammensætning af L-DOPA-estere | |
DK0377518T3 (da) | Farmaceutisk præparat med langvarig frigivelse | |
NO174412C (no) | Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse | |
IE790756L (en) | Cerebral therapeutic agent | |
ES8603870A1 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
ZA836582B (en) | Constant release rate solid oral dosage formulations of drugs having a pka7-10 and an aqueous solubility of 15-100g/ml water | |
ES2078251T3 (es) | Sistema para la distribucion regulada de agentes activos y proceso para su preparacion. | |
WO2002064148A3 (en) | Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders | |
DK1009380T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske formuleringer | |
IE44030L (en) | Ó-amino-ketones. | |
KR900701278A (ko) | 바이러스 감염 치료용 담즙산 | |
MY101266A (en) | Pharmaceutical formulations | |
IL57513A0 (en) | 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them | |
JPS643123A (en) | Remedy for skin inflammation | |
IE873463L (en) | Compositions | |
SE0000782D0 (sv) | Pharmaceutical formulation and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 381181 Country of ref document: ES |